Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Wpływ inhibitorów receptora limfocytów B na regulację CD20 w komórkach nowotworowych

2014/12/T/NZ6/00337

Keywords:

Descriptors:

  • NZ6_1: Adaptive and innate immunity
  • NZ6_8: Other related subjects

Panel:

NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution :

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

Kamil Bojarczuk 

Number of co-investigators in the project: 2

Call: ETIUDA 2 - announced on 2013-12-16

Amount awarded: 77 970 PLN

Project start date (Y-m-d): 2014-10-01

Project end date (Y-m-d): 2015-06-30

Project duration:: 9 months (the same as in the proposal)

Project status: Project settled

Information in the final report

  • Publication in academic press/journals (3)
  • Articles in post-conference publications (1)
  1. B-cell receptor signaling in the pathogenesis of lymphoid malignancies
    Authors:
    Bojarczuk K*, Bobrowicz M*, Dwojak M, Miazek N, Zapala P, Bunes A, Siernicka M, Rozanska M, Winiarska M * - równorzędni współautorzy
    Academic press:
    Blood Cells Molecules and Diseases (rok: 2015, tom: 55, strony: 255-265), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bcmd.2015.06.016 - link to the publication
  2. BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199
    Authors:
    Kamil Bojarczuk*, Binu K Sasi*, Stefania Gobessi, Idanna Innocenti, Gabriele Pozzato, Luca Laurenti, and Dimitar G Efremov * - równorzędni współautorzy
    Academic press:
    Blood (rok: 2016, ), Wydawca: American Society of Hematology
    Status:
    Published
    DOI:
    10.1182/blood-2015-10-675009 - link to the publication
  3. Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
    Authors:
    Dwojak M, Bobrowicz M, Bil J, Bojarczuk K, Pyrzynska B, Siernicka M, Malenda A, Lech-Maranda E, Tomczak W, Giannopoulos K, Golab J, Winiarska M
    Academic press:
    Blood Cancer Journal (rok: 2015, tom: 5, strony: e300), Wydawca: Nature Publishing Group
    Status:
    Published
    DOI:
    10.1038/bcj.2015.27 - link to the publication
  1. Inhibition of SYK More Effectively Overcomes MCL-1 Mediated ABT-199 Resistance of BCR-Stimulated CLL Cells Than Inhibition of BTK or PI3Kdelta
    Authors:
    Kamil Bojarczuk, Binu K Sasi, Stefania Gobessi, Idanna Innocenti, Luca Laurenti and Dimitar G Efremov
    Conference:
    57th ASH Annual Meeting and Exposition (rok: 2015, ), Wydawca: American Society of Hematology
    Data:
    konferencja 5-8.12.2015
    Status:
    Published
    DOI:
    link to the publication

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy